Effect of Carvedilol and Nebivolol on Oxidative Stress-related Parameters and Endothelial Function in Patients with Essential Hypertension

The Effects of Newer Beta-Adrenoceptor Antagonists on Vascular Function in Cardiovascular Disease

(2012) Markus Wehland et al.   Current Vascular Pharmacology

Blood pressure in relation to neurogenic, inflammatory and endothelial dysfunction biomarkers in patients with treated essential arterial hypertension

(2011) AM Tycinska et al.   Advances in Medical Sciences

Relationships Among Hyperuricemia, Metabolic Syndrome, and Endothelial Function

(2011) H. Tomiyama et al.   AMERICAN JOURNAL OF HYPERTENSION

Effects of Antihypertensive Treatment on Endothelial Function

(2011) Agostino Virdis et al.   CURRENT HYPERTENSION REPORTS

Beta-Blockers in Hypertension

(2010) C. Venkata S. Ram   AMERICAN JOURNAL OF CARDIOLOGY

Adrenergic Receptor Blockade Reverses Right Heart Remodeling and Dysfunction in Pulmonary Hypertensive Rats

(2010) Harm J. Bogaard et al.   AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE

Relationship between mean platelet volume levels and subclinical target organ damage in newly diagnosed hypertensive patients

(2010) Mikail Yarlioglues et al.   BLOOD PRESSURE

Differential Effects of Carvedilol and Metoprolol on Renal Function in Patients With Heart Failure

(2010) Hiroyuki Ito et al.   CIRCULATION JOURNAL

Current role of beta-blockers in the treatment of hypertension

(2010) Wilbert S Aronow   EXPERT OPINION ON PHARMACOTHERAPY

Nebivolol

(2009) Claudine M. Baldwin et al.   American Journal of Cardiovascular Drugs

Effect of carvedilol on coronary flow reserve in patients with hypertensive left-ventricular hypertrophy

(2009) Huang Xiaozhen et al.   BLOOD PRESSURE

Reactive Oxygen Species and Dopamine Receptor Function in Essential Hypertension

(2009) Chunyu Zeng et al.   CLINICAL AND EXPERIMENTAL HYPERTENSION

Evolving Mechanisms of Action of Beta Blockers: Focus on Nebivolol

(2009) R Preston Mason et al.   JOURNAL OF CARDIOVASCULAR PHARMACOLOGY

Realities of Newer β-Blockers for the Management of Hypertension

(2009) Camila Manrique et al.   Journal of Clinical Hypertension

Comparison of Nebivolol Monotherapy Versus Nebivolol in Combination With Other Antihypertensive Therapies for the Treatment of Hypertension

(2008) Vasilios Papademetriou   AMERICAN JOURNAL OF CARDIOLOGY

Nebivolol Treatment Reduces Serum Levels of Asymmetric Dimethylarginine and Improves Endothelial Dysfunction in Essential Hypertensive Patients

(2008) A. F. Pasini et al.   AMERICAN JOURNAL OF HYPERTENSION

Different Pharmacological Properties of Two Enantiomers in a Unique β-Blocker, Nebivolol

(2008) Louis J. Ignarro   Cardiovascular Therapeutics